Vitamin D and the promotion of long-term metabolic health from a programming perspective

Nutrition and Metabolic Insights

Volumn 8, Issue , 2015, Pages 11-21

  Palaniswamy, Saranya ^a   Williams, Dylan ^b   Järvelin, Marjo Riitta ^a,b,c   Sebert, Sylvain ^a  

^a UNIVERSITY OF OULU   (Finland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Fetal programming; Inflammation; Maternal outcomes; Vitamin D

Indexed keywords

EID: 85041083685     PISSN: None     EISSN: 11786388     Source Type: Journal    
DOI: 10.4137/NMI.S29526     Document Type: Review

References (158)

1. Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591-608.
2. Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358(9292):1500-1503.
3. Vimaleswaran KS, Berry DJ, Lu C, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013;10(2):e1001383.
4. Vimaleswaran KS, Cavadino A, Berry DJ, et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a Mendelian randomization study. Lancet Diabetes Endocrinol. 2014;2(9):719-729.
5. Kabadi SM, Liu L, Auchincloss AH, et al. Multivariate path analysis of serum 25-hydroxyvitamin D concentration, inflammation, and risk of type 2 diabetes mellitus. Dis Markers. 2013;35(3):187-193.
6. Buckley BS, Harreiter J, Damm P, et al. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med. 2012;29(7):844-854.
7. Koivunen S, Kajantie E, Torkki A, et al. The changing face of gestational diabetes: the effect of the shift from risk factor-based to comprehensive screening. Eur J Endocrinol. 2015;173(5):623-632.
8. Pirkola J, Pouta A, Bloigu A, et al. Prepregnancy overweight and gestational diabetes as determinants of subsequent diabetes and hypertension after 20-year follow-up. J Clin Endocrinol Metab. 2010;95(2):772-778.
9. Pirkola J, Pouta A, Bloigu A, et al. Risks of overweight and abdominal obesity at age 16 years associated with prenatal exposures to maternal prepregnancy overweight and gestational diabetes mellitus. Diabetes Care. 2010;33(5):1115-1121.
10. Rodriguez A. Maternal pre-pregnancy obesity and risk for inattention and negative emotionality in children. J Child Psychol Psychiatry. 2010;51(2):134-143.
11. Fernandes C, Grayton H, Poston L, et al. Prenatal exposure to maternal obesity leads to hyperactivity in offspring. Mol Psychiatry. 2012;17(12):1159-1160.
12. Sovio U, Kaakinen M, Tzoulaki I, et al. How do changes in body mass index in infancy and childhood associate with cardiometabolic profile in adulthood? findings from the northern Finland birth cohort 1966 study. Int J Obes (Lond). 2014; 38(1):53-59.
13. Gishti O, Gaillard R, Felix JF, et al. Early origins of ethnic disparities in cardio- vascular risk factors. Prev Med. 2015;76:84-91.
14. Horikoshi M, Yaghootkar H, Mook-Kanamori DO, et al. New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet. 2013;45(1):76-82.
15. Dellschaft NS, Alexandre-Gouabau MC, Gardner DS, et al. Effect of pre- and postnatal growth and post-weaning activity on glucose metabolism in the offspring. J Endocrinol. 2015;224(2):171-182.
16. Sebert SP, Dellschaft NS, Chan LL, et al. Maternal nutrient restriction during late gestation and early postnatal growth in sheep differentially reset the control of energy metabolism in the gastric mucosa. Endocrinology. 2011;152(7): 2816-2826.
17. Ojha S, Fainberg HP, Sebert S, et al. Maternal health and eating habits: metabolic consequences and impact on child health. Trends Mol Med. 2015;21(2):126-133.
18. Mutt SJ, Hypponen E, Saarnio J, et al. Vitamin D and adipose tissue-more than storage. Front Physiol. 2014;5:228.
19. Symonds ME, Sebert SP, Hyatt MA, et al. Nutritional programming of the metabolic syndrome. Nat Rev Endocrinol. 2009;5(11):604-610.
20. Sebert SP, Hyatt MA, Chan LL, et al. Influence of prenatal nutrition and obesity on tissue specific fat mass and obesity-associated (FTO) gene expression. Reproduction. 2010;139(1):265-274.
21. Sebert SP, Hyatt MA, Chan LL, et al. Maternal nutrient restriction between early and midgestation and its impact upon appetite regulation after juvenile obesity. Endocrinology. 2009;150(2):634-641.
22. Taib B, Bouyakdan K, Hryhorczuk C, et al. Glucose regulates hypothalamic long-chain fatty acid metabolism via AMP-activated kinase (AMPK) in neurons and astrocytes. J Biol Chem. 2013;288(52):37216-37229.
23. Sharkey D, Gardner DS, Fainberg HP, et al. Maternal nutrient restriction during pregnancy differentially alters the unfolded protein response in adipose and renal tissue of obese juvenile offspring. FASEB J. 2009;23(5):1314-1324.
24. Lumey LH, Ravelli AC, Wiessing LG, et al. The Dutch famine birth cohort study: Design, validation of exposure, and selected characteristics of subjects after 43 years follow-up. Paediatr Perinat Epidemiol. 1993;7(4):354-367.
25. Lumey LH, Stein AD, Ravelli AC. Timing of prenatal starvation in women and birth weight in their first and second born offspring: the Dutch famine birth cohort study. Eur J Obstet Gynecol Reprod Biol. 1995;61(1):23-30.
26. Sebert S, Salonurmi T, Keinanen-Kiukaanniemi S, et al. Programming effects of FTO in the development of obesity. Acta Physiol (Oxf). 2014;210(1):58-69.
27. Perez-Lopez FR. Vitamin D: the secosteroid hormone and human reproduction. Gynecol Endocrinol. 2007;23(1):13-24.
28. Maghbooli Z, Hossein-Nezhad A, Shafaei AR, et al. Vitamin D status in mothers and their newborns in Iran. BMC Pregnancy Childbirth. 2007;7:1.
29. Markestad T, Aksnes L, Ulstein M, et al. 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D ofD2 and D3 origin in maternal and umbilical cord serum after vitamin D2 supplementation in human pregnancy. Am J Clin Nutr. 1984; 40(5):1057-1063.
30. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130-137.
31. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066-1074.
32. Bodnar LM, Catov JM, Simhan HN, et al. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007;92(9):3517-3522.
33. Baker AM, Haeri S, Camargo CA Jr, et al. A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. J Clin Endocrinol Metab. 2010;95(11):5105-5109.
34. Wei SQ. Vitamin D and pregnancy outcomes. Curr Opin Obstet Gynecol. 2014; 26(6):438-447.
35. Achkar M, Dodds L, Giguere Y, et al. Vitamin D status in early pregnancy and risk of preeclampsia. Am J Obstet Gynecol. 2015;212(4):e1-.e511.
36. Hypponen E, Cavadino A, Williams D, et al. Vitamin D and pre-eclampsia: original data, systematic review and meta-analysis. Ann Nutr Metab. 2013;63(4): 331-340.
37. Aghajafari F, Nagulesapillai T, Ronksley PE, et al. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ. 2013;346:f1169.
38. Wei SQ, Qi HP, Luo ZC, et al. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2013;26(9):889-899.
39. Tabesh M, Salehi-Abargouei A, Tabesh M, et al. Maternal vitamin D status and risk of pre-eclampsia: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2013;98(8):3165-3173.
40. Diaz L, Arranz C, Avila E, et al. Expression and activity of 25-hydroxyvitamin D-1 alpha-hydroxylase are restricted in cultures of human syncytiotrophoblast cells from preeclamptic pregnancies. J Clin Endocrinol Metab. 2002; 87(8):3876-3882.
41. Barrera D, Diaz L, Noyola-Martinez N, et al. Vitamin D and inflammatory cytokines in healthy and preeclamptic pregnancies. Nutrients. 2015;7(8):6465-6490.
42. Halhali A, Diaz L, Avila E, et al. Decreased fractional urinary calcium excretion and serum 1,25-dihydroxyvitamin D and IGF-I levels in preeclampsia. J Steroid Biochem Mol Biol. 2007;103(3-5):803-806.
43. Seely EW, Wood RJ, Brown EM, et al. Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia. J Clin Endocrinol Metab. 1992;74(6):1436-1440.
44. Taufield PA, Ales KL, Resnick LM, et al. Hypocalciuria in preeclampsia. N Engl J Med. 1987;316(12):715-718.
45. Pedersen EB, Johannesen P, Kristensen S, et al. Calcium, parathyroid hormone and calcitonin in normal pregnancy and preeclampsia. Gynecol Obstet Invest. 1984;18(3):156-164.
46. Halhali A, Tovar AR, Torres N, et al. Preeclampsia is associated with low cir- culating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab. 2000; 85(5):1828-1833.
47. Halhali A, Bourges H, Carrillo A, et al. Lower circulating insulin-like growth factor I and 1,25-dihydroxyvitamin D levels in preeclampsia. Rev Invest Clin. 1995;47(4):259-266.
48. Halhali A, Diaz L, Barrera D, et al. Placental calcitriol synthesis and IGF-I levels in normal and preeclamptic pregnancies. J Steroid Biochem Mol Biol. 2014; 144 PtA:44-49.
49. Olmos A, Diaz L, Avila E, et al. Associations between insulin-like growth factor I, vascular endothelial growth factor and its soluble receptor 1 in umbilical serum and endothelial cells obtained from normotensive and preeclamptic pregnancies. Growth Factors. 2013;31(4):123-129.
50. Sifakis S, Akolekar R, Kappou D, et al. Maternal serum insulin-like growth factor-I at 11-13 weeks in preeclampsia. Prenat Diagn. 2010;30(11):1026-1031.
51. Yadav S, Yadav YS, Goel MM, et al. Calcitonin gene- and parathyroid hormonerelated peptides in normotensive and preeclamptic pregnancies: a nested case- control study. Arch Gynecol Obstet. 2014;290(5):897-903.
52. Shang LX, Wang J, Zhang LJ, et al. Relationship between changes of insulin like growth factor-1 and insulin like growth factor binding protein-1 in maternal serum and placenta and pathogenesis of hypertensive disorder complicating pregnancy. Zhonghua Fu Chan Ke Za Zhi. 2005;40(8):516-520.
53. Dubova EA, Pavlov KA, Lyapin VM, et al. Expression of insulin-like growth factors in the placenta in preeclampsia. Bull Exp Biol Med. 2014;157(1):103-107.
54. LaMarca B, Cornelius D, Wallace K. Elucidating immune mechanisms causing hypertension during pregnancy. Physiology (Bethesda). 2013;28(4):225-233.
55. Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol. 2013;94(2):247-257.
56. Perez-Sepulveda A, Torres MJ, Khoury M, et al. Innate immune system and preeclampsia. Front Immunol. 2014;5:244.
57. Saito S, Sakai M, Sasaki Y, et al. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol. 1999;117(3):550-555.
58. Szarka A, Rigo J Jr, Lazar L, et al. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010;11:59.
59. Lau SY, Guild SJ, Barrett CJ, et al. Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. Am J Reprod Immunol. 2013;70(5):412-427.
60. Xie C, Yao MZ, Liu JB, et al. A meta-analysis of tumor necrosis factoralpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine. 2011;56(3): 550-559.
61. HAPO Study Cooperative Research Group. The hyperglycemia and adverse pregnancy outcome (HAPO) study. Int J Gynaecol Obstet. 2002;78(1):69-77.
62. International Association of Diabetes and Pregnancy Study Groups Consensus Panel; Metzger BE, Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676-682.
63. Lewis S, Lucas RM, Halliday J, et al. Vitamin D deficiency and pregnancy: from preconception to birth. Mol Nutr Food Res. 2010;54(8):1092-1102.
64. Poel YH, Hummel P, Lips P, et al. Vitamin D and gestational diabetes: a systematic review and meta-analysis. Eur J Intern Med. 2012;23(5):465-469.
65. Burris HH, Camargo CA Jr. Vitamin D and gestational diabetes mellitus. Curr Diab Rep. 2014;14(1):451.
66. Joergensen JS, Lamont RF, Torloni MR. Vitamin D and gestational diabetes: an update. Curr Opin Clin Nutr Metab Care. 2014;17(4):360-367.
67. El Lithy A, Abdella RM, El-Faissal YM, et al. The relationship between low maternal serum vitamin D levels and glycemic control in gestational diabetes assessed by HbA1c levels: an observational cross-sectional study. BMC Preg- nancy Childbirth. 2014;14:362.
68. Jelsma JG, van Poppel MN, Galjaard S, et al. DALI: vitamin D and lifestyle intervention for gestational diabetes mellitus (GDM) prevention: an European multicentre, randomised trial-study protocol. BMC Pregnancy Childbirth. 2013; 13:142.
69. Gernand AD, Simhan HN, Klebanoff MA, et al. Maternal serum 25-hydroxyvitamin D and measures of newborn and placental weight in a U.S. multicenter cohort study. J Clin Endocrinol Metab. 2013;98(1):398-404.
70. Gernand AD, Bodnar LM, Klebanoff MA, et al. Maternal serum 25-hydroxyvitamin D and placental vascular pathology in a multicenter US cohort. Am J Clin Nutr. 2013;98(2):383-388.
71. Schneuer FJ, Roberts CL, Guilbert C, et al. Effects of maternal serum 25-hydroxyvitamin D concentrations in the first trimester on subsequent pregnancy outcomes in an Australian population. Am J Clin Nutr. 2014;99(2):287-295.
72. van den Berg G, van Eijsden M, Vrijkotte TG, et al. Suboptimal maternal vitamin D status and low education level as determinants of small-for-gestational- age birth weight. Eur J Nutr. 2013;52(1):273-279.
73. Chen YH, Fu L, Hao JH, et al. Maternal vitamin D deficiency during pregnancy elevates the risks of small for gestational age and low birth weight infants in Chinese population. J Clin Endocrinol Metab. 2015;100(5):1912-1919.
74. Luderer HF, Nazarian RM, Zhu ED, et al. Ligand-dependent actions of the vitamin D receptor are required for activation of TGF-beta signaling during the inflammatory response to cutaneous injury. Endocrinology. 2013;154(1): 16-24.
75. Cotechini T, Komisarenko M, Sperou A, et al. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J Exp Med. 2014;211(1):165-179.
76. Liu NQ, Kaplan AT, Lagishetty V, et al. Vitamin D and the regulation of placental inflammation. J Immunol. 2011;186(10):5968-5974.
77. Xu DX, Chen YH, Wang H, et al. Tumor necrosis factor alpha partially contributes to lipopolysaccharide-induced intra-uterine fetal growth restriction and skeletal development retardation in mice. Toxicol Lett. 2006;163(1):20-29.
78. Tosun M, Celik H, Avci B, et al. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia. J Matern Fetal Neonatal Med. 2010;23(8):880-886.
79. Shin JS, Choi MY, Longtine MS, et al. Vitamin D effects on pregnancy and the placenta. Placenta. 2010;31(12):1027-1034.
80. Henry HL, Norman AW. Vitamin D: metabolism and biological actions. Annu Rev Nutr. 1984;4:493-520.
81. Stephanou A, Ross R, Handwerger S. Regulation of human placental lactogen expression by 1,25-dihydroxyvitamin D3. Endocrinology. 1994;135(6):2651-2656.
82. Barrera D, Avila E, Hernandez G, et al. Estradiol and progesterone synthesis in human placenta is stimulated by calcitriol. J Steroid Biochem Mol Biol. 2007;103(3-5):529-532.
83. Barrera D, Avila E, Hernandez G, et al. Calcitriol affects hCG gene transcription in cultured human syncytiotrophoblasts. Reprod Biol Endocrinol. 2008;6:3.
84. Billaudel B, Labriji-Mestaghanmi H, Sutter BC, et al. Vitamin D and pancreatic islet function. II. Dynamics of insulin release and cationic fluxes. J Endocrinol Invest. 1988;11(8):585-593.
85. Halhali A, Acker GM, Garabedian M. 1,25-dihydroxyvitamin D3 induces in vivo the decidualization of rat endometrial cells. J Reprod Fertil. 1991;91(1): 59-64.
86. Du H, Daftary GS, Lalwani SI, et al. Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Mol Endocrinol. 2005;19(9):2222-2233.
87. Zehnder D, Evans KN, Kilby MD, et al. The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am J Pathol. 2002;161(1):105-114.
88. Diaz L, Noyola-Martinez N, Barrera D, et al. Calcitriol inhibits TNF-alpha- induced inflammatory cytokines in human trophoblasts. J Reprod Immunol. 2009; 81(1):17-24.
89. Liu N, Kaplan AT, Low J, et al. Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol Reprod. 2009;80(3): 398-406.
90. Evans KN, Nguyen L, Chan J, et al. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod. 2006;75(6):816-822.
91. Wagner CL, Baggerly C, McDonnell SL, et al. Post-hoc comparison of vitamin D status at three timepoints during pregnancy demonstrates lower risk of preterm birth with higher vitamin D closer to delivery. J Steroid Biochem Mol Biol. 2015;148:256-260.
92. Morales E, Rodriguez A, Valvi D, et al. Deficit of vitamin D in pregnancy and growth and overweight in the offspring. Int J Obes (Lond). 2015;39(1):61-68.
93. Crozier SR, Harvey NC, Inskip HM, et al. Maternal vitamin D status in pregnancy is associated with adiposity in the offspring: findings from the Southampton Women’s Survey. Am J Clin Nutr. 2012;96(1):57-63.
94. Leffelaar ER, Vrijkotte TG, van Eijsden M. Maternal early pregnancy vitamin D status in relation to fetal and neonatal growth: results of the multiethnic Amsterdam born children and their development cohort. Br J Nutr. 2010; 104(1):108-117.
95. Reichetzeder C, Chen H, Foller M, et al. Maternal vitamin D deficiency and fetal programming - lessons learned from humans and mice. Kidney Blood Press Res. 2014;39(4):315-329.
96. Krishnaveni GV, Veena SR, Winder NR, et al. Maternal vitamin D status during pregnancy and body composition and cardiovascular risk markers in Indian children: the Mysore Parthenon Study. Am J Clin Nutr. 2011;93(3): 628-635.
97. Tesic D, Hawes JE, Zosky GR, et al. Vitamin D deficiency in BALB/c mouse pregnancy increases placental transfer of glucocorticoids. Endocrinology. 2015;156(10):3673-3679.
98. Liu NQ, Ouyang Y, Bulut Y, et al. Dietary vitamin D restriction in pregnant female mice is associated with maternal hypertension and altered placental and fetal development. Endocrinology. 2013;154(7):2270-2280.
99. Zhang H, Chu X, Huang Y, et al. Maternal vitamin D deficiency during pregnancy results in insulin resistance in rat offspring, which is associated with inflammation and Iκbα. Diabetologia. 2014;57(10):2165-2172.
100. Perez-Lopez FR, Pasupuleti V, Mezones-Holguin E, et al. Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2015;103(5):1278.e-1288.e.
101. Bhalla AK, Amento EP, Clemens TL, et al. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983;57(6):1308-1310.
102. Provvedini DM, Tsoukas CD, Deftos LJ, et al. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983;221(4616):1181-1183.
103. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147(12):5542-5548.
104. Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010;9(12):941-955.
105. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88(2): 491S-499S.
106. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26(5):662-687.
107. Mutt SJ, Karhu T, Lehtonen S, et al. Inhibition of cytokine secretion from adipocytes by 1,25-dihydroxyvitamin D3via the NF-kappaB pathway. FASEB J. 2012;26(11):4400-4407.
108. Kraichely DM, MacDonald PN. Transcriptional activation through the vitamin D receptor in osteoblasts. Front Biosci. 1998;3:d821-d833.
109. Szodoray P, Nakken B, Gaal J, et al. The complex role of vitamin D in autoimmune diseases. Scand J Immunol. 2008;68(3):261-269.
110. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770-1773.
111. Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf). 2012;76(3):315-325.
112. Zasloff M. Fighting infections with vitamin D. Nat Med. 2006;12(4):388-390.
113. Hewison M. Vitamin D and immune function: autocrine, paracrine or endocrine? Scand J Clin Lab Invest Suppl. 2012;243:92-102.
114. Adorini L, Penna G. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol. 2009;70(5):345-352.
115. Pancer Z, Cooper MD. The evolution of adaptive immunity. Annu Rev Immunol.2006;24:497-518.
116. Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179(3):1634-1647.
117. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008;4(2):80-90.
118. Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest. 1984;74(4):1451-1455.
119. Lemire JM, Adams JS, Sakai R, et al. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest. 1984;74(2):657-661.
120. Boonstra A, Barrat FJ, Crain C, et al. 1alpha,25-dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001;167(9):4974-4980.
121. Mahon BD, Wittke A, Weaver V, et al. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem. 2003;89(5):922-932.
122. Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol. 1995;15(10):5789-5799.
123. Cippitelli M, Santoni A. Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur J Immunol. 1998;28(10):3017-3030.
124. Takahashi K, Nakayama Y, Horiuchi H, et al. Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha,25- dihydroxyvitamin D3. Immunopharmacol Immunotoxicol. 2002;24(3):335-347.
125. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173(5):2909-2912.
126. Parikh SJ, Edelman M, Uwaifo GI, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004;89(3):1196-1199.
127. Vanlint S. Vitamin D and obesity. Nutrients. 2013;5(3):949-956.
128. Saneei P, Salehi-Abargouei A, Esmaillzadeh A. Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes Rev. 2013;14(5):393-404.
129. Pereira-Santos M, Costa PR, Assis AM, et al. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev. 2015;16(4):341-349.
130. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690-693.
131. Touvier M, Deschasaux M, Montourcy M, et al. Determinants of vitamin D status in caucasian adults: influence of sun exposure, dietary intake, sociodemographic, lifestyle, anthropometric, and genetic factors. J Invest Dermatol. 2015; 135(2):378-388.
132. Koszowska AU, Nowak J, Dittfeld A, et al. Obesity, adipose tissue function and the role of vitamin D. Cent Eur J Immunol. 2014;39(2):260-264.
133. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314(1):1-16.
134. Vlasova M, Purhonen AK, Jarvelin MR, et al. Role of adipokines in obesityassociated hypertension. Acta Physiol (Oxf). 2010;200(2):107-127.
135. Trayhurn P, Bing C, Wood IS. Adipose tissue and adipokines—energy regulation from the human perspective. J Nutr. 2006;136(7 suppl):1935S-1939S.
136. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92(3):347-355.
137. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003;112(12):1785-1788.
138. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82(12):4196-4200.
139. van Hall G, Steensberg A, Sacchetti M, et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab. 2003;88(7):3005-3010.
140. Marcotorchino J, Gouranton E, Romier B, et al. Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes. Mol Nutr Food Res. 2012;56(12):1771-1782.
141. Gao D, Trayhurn P, Bing C. 1,25-dihydroxyvitamin D3 inhibits the cytokine- induced secretion ofMCP-1 and reduces monocyte recruitment by human preadipocytes. Int J Obes (Lond). 2013;37(3):357-365.
142. Ding C, Wilding JP, Bing C. 1,25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFkappaB and MAPK signalling and chemokine release in human adipocytes. PLoS One. 2013;8(4):e61707.
143. Peterson CA, Heffernan ME. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J Inflamm (Lond). 2008;5:10.
144. Willis KS, Smith DT, Broughton KS, et al. Vitamin D status and biomarkers of inflammation in runners. Open Access J Sports Med. 2012;3:35-42.
145. Laird E, McNulty H, Ward M, et al. Vitamin D deficiency is associated with inflammation in older Irish adults. J Clin Endocrinol Metab. 2014;99(5):1807-1815.
146. De Vita F, Lauretani F, Bauer J, et al. Relationship between vitamin D and inflammatory markers in older individuals. Age (Dordr). 2014;36(4):9694.
147. Sun X, Cao ZB, Zhang Y, et al. Association between serum 25-hydroxyvitamin D and inflammatory cytokines in healthy adults. Nutrients. 2014;6(1):221-230.
148. Ye Z, Sharp SJ, Burgess S, et al. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a Mendelian Randomisation Study. Lancet Diabetes Endocrinol. 2015;3(1):35-42.
149. Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol. 2013;31:387-411.
150. Vijayendra Chary A, Hemalatha R, Seshacharyulu M, et al. Reprint of “vitamin D deficiency in pregnant women impairs regulatory T cell function”. J Steroid Biochem Mol Biol. 2015;148:194-201.
151. Jones AP, D’Vaz N, Meldrum S, et al. 25-hydroxyvitamin D3 status is associated with developing adaptive and innate immune responses in the first 6 months of life. Clin Exp Allergy. 2015;45(1):220-231.
152. Zittermann A, Dembinski J, Stehle P. Low vitamin D status is associated with low cord blood levels of the immunosuppressive cytokine interleukin-10. PediatrAllergy Immunol. 2004;15(3):242-246.
153. Bhutta ZA, Das JK, Rizvi A, et al. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet. 2013;382(9890):452-477.
154. Ponsonby AL, Lucas RM, Lewis S, et al. Vitamin D status during pregnancy and aspects of offspring health. Nutrients. 2010;2(3):389-407.
155. Bendik I, Friedel A, Roos FF, et al. Vitamin D: a critical and essential micronutrient for human health. Front Physiol. 2014;5:248.
156. Jacobsen R, Hypponen E, Sorensen TI, et al. Gestational and early infancy exposure to margarine fortified with vitamin D through a National Danish Programme and the risk of type 1 diabetes: the D-Tect study. PLoS One. 2015;10(6): e0128631.
157. Shea MK, Booth SL, Massaro JM, et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham offspring study. Am J Epidemiol. 2008;167(3):313-320.
158. Barker T, Martins TB, Hill HR, et al. Circulating pro-inflammatory cytokines are elevated and peak power output correlates with 25-hydroxyvitamin D in vitamin D insufficient adults. Eur J Appl Physiol. 2013;113(6):1523-1534.